Thursday September 10, 2020
Minneapolis (HOL) – A Minnesota health care provider has suspended a COVID-19 vaccine after it has been reported that recipient’s during the trial had severe side effects.
Bloomington-based HealthPartners announced that it has suspended that trials led by AstraZeneca and Oxford University after one of the patients developed an unexplained illness. AstraZeneca said it’s investigating whether the sickness was a side-effect of the drug.
The interest in the vaccine was immense. HealthPartners filled about 1,000 of its 1,500 slots in the national trial in 24 hours last week.
There are currently dozens of COVID vaccines being developed around the world, with nearly a half dozen already in phase 2 trials.